Yawen Xu

253 Middle Gongye Avenue Road
Guangzhou, 510280, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902.

RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902.

Journal: Cancers

Published: April 08, 2026

Safety and efficacy of the Chinese surgical robotic system (EDGE MP1000 & MP2000) for robot-assisted radical prostatectomy: results from a single high-volume center.

Safety and efficacy of the Chinese surgical robotic system (EDGE MP1000 & MP2000) for robot-assisted radical prostatectomy: results from a single high-volume center.

Journal: Journal of robotic surgery

Published: October 29, 2025

Multimodal deep learning model for AI-based functional prognostic risk stratification in patients undergoing radical nephrectomy.

Multimodal deep learning model for AI-based functional prognostic risk stratification in patients undergoing radical nephrectomy.

Journal: Nature communications

Published: July 31, 2025

LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway.

LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway.

Journal: Cancers

Published: January 05, 2023

miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.

miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.

Journal: Cancer biomarkers : section A of Disease markers

Published: August 13, 2019

CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer.

CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer.

Journal: Archives of medical science : AMS

Published: December 23, 2018

Dual-centre randomized-controlled trial comparing transurethral endoscopic enucleation of the prostate using diode laser vs. bipolar plasmakinetic for the treatment of LUTS secondary of benign prostate obstruction: 1-year follow-up results.

Dual-centre randomized-controlled trial comparing transurethral endoscopic enucleation of the prostate using diode laser vs. bipolar plasmakinetic for the treatment of LUTS secondary of benign prostate obstruction: 1-year follow-up results.

Journal: World journal of urology

Published: December 07, 2017

Bipolar transurethral enucleation and resection of the prostate: Whether it is ready to supersede TURP?

Bipolar transurethral enucleation and resection of the prostate: Whether it is ready to supersede TURP?

Journal: Asian journal of urology

Published: September 02, 2017

Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma.

Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma.

Journal: Oncotarget

Published: December 21, 2016

Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade.

Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade.

Journal: Biochemical and biophysical research communications

Published: December 21, 2016

IgG silencing induces apoptosis and suppresses proliferation, migration and invasion in LNCaP prostate cancer cells.

IgG silencing induces apoptosis and suppresses proliferation, migration and invasion in LNCaP prostate cancer cells.

Journal: Cellular & molecular biology letters

Published: October 26, 2016

Sodium phenylbutyrate antagonizes prostate cancer through the induction of apoptosis and attenuation of cell viability and migration.

Sodium phenylbutyrate antagonizes prostate cancer through the induction of apoptosis and attenuation of cell viability and migration.

Journal: OncoTargets and therapy

Published: June 09, 2016

Showing 1-12 of 25

Last Updated: 09/26/2026